| abstract |
FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to a novel compound, namely, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or its pharmaceutically acceptable (-)-enantiomer-free salts. This compounds is able to bind with norepinephrine and serotonin carriers that provides their using as components of pharmaceutical composition used in treatment of depression, anxiety state or nutrient disorder. n EFFECT: valuable medicinal properties of compound and pharmaceutical composition. n 16 cl, 2 tbl, 4 ex |